Agenus Inc. (AGEN) is a publicly traded Healthcare sector company. As of August 20, 2026, AGEN trades at $7.50 with a market cap of $371.78M and a P/E ratio of 2.77. AGEN moved -9.32% today. Year to date, AGEN is +131.89%; over the trailing twelve months it is +66.08%. Its 52-week range spans $1.38 to $8.85. Analyst consensus is buy with an average price target of $19.50. Rallies surfaces AGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover AGEN: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $19.50.
| Metric | Value |
|---|---|
| Price | $7.50 |
| Market Cap | $371.78M |
| P/E Ratio | 2.77 |
| EPS | $2.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.85 |
| 52-Week Low | $1.38 |
| Volume | 1.53M |
| Avg Volume | 0 |
| Revenue (TTM) | $132.69M |
| Net Income | $91.94M |
| Gross Margin | 0.00% |
2 analysts cover AGEN: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $19.50.